A Study of Amivantamab in People With Esophagogastric Cancer

Status Recruiting

Clinical Trial Summary

The purpose of this study is to see whether the study drug, amivantamab, is an effective treatment for people with EGFR- or MET-amplified esophagogastric cancer. The researchers will also look at whether amivantamab is a safe treatment that causes few or mild side effects in participants.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Esophagogastric Cancer

Clinical Trial Details

NCT number	NCT05117931
Study type	Interventional
Source	Memorial Sloan Kettering Cancer Center
Contact	Steven Maron, MD
Phone	646-888-6780
Email	marons@mskcc.org
Status	Recruiting
Phase	Phase 2
Start date	December 2, 2021
Completion date	November 2025

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05544929` - A Study of Safety and Efficacy of KFA115 Alone and in Combination With Pembrolizumab in Patients With Select Advanced Cancers	Phase 1
Recruiting	`NCT05612048` - A Study of Tooth Erosion in People With Esophagogastric Cancer	N/A
Completed	`NCT04161781` - A Study of PET Scans With the Radioactive Tracer 18F-BMS-986229 in Patients With Esophageal, Stomach, or Gastroesophageal Junction Cancer
Completed	`NCT01803282` - Study to Evaluate the Safety and Tolerability of Andecaliximab as Monotherapy and in Combination With Chemotherapy in Participants With Advanced Solid Tumors	Phase 1
Recruiting	`NCT05796102` - PET-MRI Esophagus Feasibility Study	N/A
Recruiting	`NCT04656041` - Folfox+Irinotecan+Chemort In Esophageal Cancer	Phase 2
Withdrawn	`NCT02296671` - Personalized Therapy for Esophagogastric Cancer Using Thymidylate Synthase Genetic Markers	Phase 2
Active, not recruiting	`NCT04757363` - A Study of Nivolumab Combined With FOLFOX and Regorafenib in People Who Have HER2-Negative Esophagogastric Cancer	Phase 2
Completed	`NCT02023996` - PET Imaging With 89Zr-DFO-Trastuzumab in Esophagogastric Cancer	N/A
Not yet recruiting	`NCT03760289` - DKN-01/Atezolizumab as Second Line Treatment of biliarY Tract Cancer and in combiNAtion or Not With Paclitaxel as Second Line treatMent of esophagogastrIC Cancer	Phase 2
Completed	`NCT01167114` - STA-9090 in Previously Treated Patients With Advanced Esophagogastric Cancer	Phase 2
Active, not recruiting	`NCT03133650` - A Trial of a New Type of Photodynamic Therapy (VTP) in the Treatment of Patients With Cancer of the Esophagus Who Have Trouble Swallowing	Phase 1